Filing Details
- Accession Number:
- 0001232524-16-000319
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-12 16:36:56
- Reporting Period:
- 2016-08-12
- Filing Date:
- 2016-08-12
- Accepted Time:
- 2016-08-12 16:36:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1639637 | L. Karen Smith | Connaught House, 1 Burlington Rd, Fl. 4 Dublin 4 L2 | Global Head Of R&D And Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2016-08-12 | 607 | $137.10 | 14,181 | No | 4 | P | Direct | |
Ordinary Shares | Acquisiton | 2016-08-12 | 1 | $137.26 | 14,182 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.